Trial intelligence / Profile preview

Mycophenolate vs Azathioprin in Autoimmune Hepatitis

NCT00687180Phase 4Completed

Sponsor
Rigshospitalet
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of mycophenolate mofetil in autoimmune hepatitis (AIH) (2 arms), sponsored by Rigshospitalet. Status: completed.

02

Drugs

mycophenolate mofetil
03

Conditions

autoimmune hepatitis (AIH)

Beyond the preview

Go deeper on NCT00687180.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00687180.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call